Biograil

Denmark
Copenhagen, Capital Region, Denmark

Company profile

Biograil company profile

Biograil, founded in 2019 and led by CEO Karsten Lindhardt, is using injection molding to manufacture a device contained in a standard size capsule able to deliver active substances into the gastrointestinal wall. The Biograil device avoids mechanical moving components and makes use of the body’s own peristaltic forces to facilitate the delivery of the biologic efficiently into the gastrointestinal wall.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2019-01-01, Year

Headquarters

Country code
DK
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
3
Total equity funding
$13.4M
Last funding
Seed / $10M / 2025-07-01
Last equity funding
Seed / $10M
Investors
5
Lead investors
2
Founders
3
Articles
13

Founders and investors

Founders

John BarberichKarsten LindhardtNikolaj Skak

Lead investors

HTGF (High-Tech Gruenderfonds)Verve Ventures

Investors

Arve CapitalHTGF (High-Tech Gruenderfonds)Megatrend InvestSwiss Investment groupVerve Ventures